The effects of sulphasalazine on urinary excretion of the hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis

Yonsei Medical Journal

Volumn 43, Issue 4, 2002, Pages 435-440

  Dilek, Keskin ^a,e   Ali, Inal ^b   Goksal, Keskin ^c   Huseyin, Tutkak ^d   Guner, Tokgoz ^d  

^a ANKARA NUMUNE HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c Department of Immunology/Rheumatology   (Turkey)

^d ANKARA UNIVERSITY   (Turkey)

^e NONE   (Turkey)

Author keywords

Pyridinium crosslinks; Rheumatoid arthritis; Sulphasalazine

Indexed keywords

AURANOFIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CHLOROQUINE; COLLAGEN; DEOXYPYRIDINOLINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PYRIDINOLINE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; BONE DESTRUCTION; CLINICAL FEATURE; CONNECTIVE TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS LINKING; DISEASE ACTIVITY; DRUG EFFECT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; RHEUMATOID ARTHRITIS; TISSUE METABOLISM; URINALYSIS; URINARY EXCRETION;

EID: 0036670307     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2002.43.4.435     Document Type: Article

References (37)

1. Urinary hydroxypyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases
2. An enzyme-linked immunoassay for the collagen crosslink pyridoline
3. The diagnostic validity of urinary free pyridolines to identify women at risk of osteoporosis
4. Osteoporosis in rheumatoid arthritis
5. Bone turnover in early rheumatoid arthritis. 2. longitudinal bone density studies
6. Pyridinium crosslinks of bone collagen and their location in peptides isolated from rat femur
7. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography
8. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
9. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
10. Health status assessment in early rheumatoid arthritis. Evidence of sensitivity in a double blind trial
11. Reduced bone formation in non-steroid treated patients with rheumatoid arthritis
12. Bone turnover in rheumatoid arthritis
13. Investigation of the metabolic activity of bone in rheumatoid arthritis
14. The early radiological signs of rheumatoid arthritis
15. Bone mineral density in patients with recent onset rheumatoid arthritis:Influence of disease activity and functional capacity
16. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture
17. Relationship of urinary pyridinium crosslinks to disease extent and activity in osteoarthritis
18. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases
19. Urinary excretion of hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis
20. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis
21. Measurement of the crosslinking compound, pyridinoline, in urine as an index of collagen degradation in joint disease
22. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis
23. Markers of bone metabolism in post menopausal women with rheumatoid arthritis
24. Serum Concentrations of interleukin 6, osteocalcin, intact parathyroid hormone and markers of bone resorption in patients with rheumatoid arthritis
25. Effects of nonsteroidal anti-inflammatory drugs (NSAID) on the metabolism of osteoarthritic cartilage in vivo
26. The effect of sulphasalazine on the urinary excretion of pyridinium crosslinks in patients with rheumatoid arthritis
27. Levels of serum and synovial fluid pyridinium crosslinks in patients with Rheumatoid arthritis
28. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis
29. Markers of bone, cartilage and synovium tissue metabolism in patients with knee osteoarthritis
30. Assessment of urinary hydroxypyridinium cross-links measurement in osteoarthritis
31. Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders
32. Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures
33. A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis
34. The engineered human anti-tumor necrosis factor alpha antibody CDP571 inhibits inflammatory pathways but not T cell activation in patients with RA
35. Urinary crosslink proteins as a marker of disease extent and activity in osteoarthritis
36. Bone metabolism in patients with rheumatoid arthritis
37. Vertebral osteoporosis in rheumatoid arthritis patients:Effect of low dose prednisone therapy